|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1037
|
$961B |
15.1x |
33.3x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$227
|
$575B |
6.1x |
16.1x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$223
|
$457B |
7.5x |
17.5x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 351
|
$385B |
4.9x |
12.3x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£136
|
$312B |
5.3x |
15.1x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 115
|
$303B |
5.4x |
13.1x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$110
|
$297B |
4.6x |
10.0x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 370
|
$269B |
5.6x |
11.5x |
|
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$579
|
$247B |
5.6x |
22.1x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$342
|
$229B |
6.3x |
13.0x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$196B |
3.2x |
7.9x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$142
|
$194B |
6.6x |
12.1x |
|
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$219
|
$169B |
6.9x |
22.1x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$55
|
$147B |
3.1x |
7.8x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€79
|
$128B |
2.4x |
8.0x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£19
|
$123B |
2.8x |
8.2x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$470
|
$115B |
9.6x |
21.2x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€45
|
$90.3B |
1.7x |
8.0x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 8801
|
$86.7B |
10.9x |
21.3x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5242
|
$79.5B |
2.7x |
10.1x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€126
|
$75.4B |
3.0x |
10.5x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 181
|
$69.8B |
4.2x |
12.5x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$741
|
$61.8B |
4.3x |
12.3x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$125
|
$60.2B |
6.4x |
14.6x |
|
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€255
|
$58.4B |
6.7x |
21.7x |
|
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$56.7B |
3.7x |
15.0x |
|
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1745000
|
$55.3B |
13.8x |
29.8x |
|
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$670
|
$54.4B |
12.7x |
36.4x |
|
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$230
|
$52.4B |
3.2x |
13.9x |
|
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 525
|
$51.6B |
5.3x |
18.2x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 101
|
$50.3B |
2.9x |
9.7x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 58
|
$49.7B |
10.5x |
34.7x |
|
argenx
|
Belgium |
Drug Development & Therapeutics
|
€704
|
$47.7B |
11.2x |
39.5x |
|
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 144
|
$45.6B |
8.7x |
37.5x |
|
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€47
|
$44.5B |
1.7x |
9.9x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$338
|
$43.2B |
11.6x |
61.7x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1610
|
$39.5B |
6.5x |
22.6x |
|
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$134
|
$39.5B |
5.7x |
19.5x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 61
|
$38.0B |
3.4x |
15.6x |
|
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 96
|
$37.4B |
5.9x |
12.9x |
|
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 215
|
$36.6B |
7.0x |
69.8x |
|
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 210000
|
$33.1B |
11.6x |
32.3x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$157
|
$32.4B |
62.9x |
-28.9x |
|
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$231
|
$31.4B |
14.2x |
-94.7x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2836
|
$31.3B |
2.4x |
11.7x |
|
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1373
|
$30.2B |
7.5x |
24.1x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 9241
|
$29.4B |
1.9x |
7.8x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$180
|
$29.0B |
3.0x |
9.5x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$13
|
$28.6B |
2.0x |
6.9x |
|
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$272
|
$28.4B |
2.0x |
11.9x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2144
|
$27.5B |
2.1x |
9.0x |
|
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$187
|
$26.8B |
2.4x |
12.2x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 39
|
$25.5B |
12.1x |
31.5x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$42
|
$24.9B |
8.4x |
8.6x |
|
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€188
|
$24.3B |
6.9x |
22.6x |
|
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$145
|
$23.4B |
5.5x |
19.7x |
|
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$371
|
$23.1B |
7.3x |
20.4x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 8
|
$21.5B |
2.1x |
5.9x |
|
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$102
|
$21.0B |
6.5x |
44.0x |
|
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 37
|
$18.5B |
6.0x |
17.3x |
|
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$256
|
$18.3B |
6.8x |
28.2x |
|
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€68
|
$18.2B |
2.1x |
9.6x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$17.5B |
2.0x |
8.1x |
|
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6056
|
$17.2B |
15.2x |
46.8x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$469
|
$17.1B |
5.3x |
10.2x |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 81
|
$17.0B |
8.8x |
86.4x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$97
|
$17.0B |
4410.5x |
-15.0x |
|
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$180
|
$16.8B |
2.1x |
10.7x |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$100
|
$16.8B |
3.4x |
10.6x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 2022
|
$16.4B |
4.5x |
11.7x |
|
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$582
|
$16.2B |
6.5x |
29.4x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 278
|
$16.1B |
50.7x |
N/A |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$77
|
$16.0B |
32.4x |
-34.9x |
|
Guardant Health
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$114
|
$15.6B |
16.1x |
-73.4x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$24
|
$15.5B |
3.3x |
17.4x |
|
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 413000
|
$15.0B |
96.7x |
180.0x |
|
Torrent Pharmaceuticals
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3997
|
$15.0B |
10.8x |
33.0x |
|
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$109
|
$14.8B |
5.2x |
17.4x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 337
|
$14.4B |
4.5x |
11.7x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$14.1B |
2.9x |
11.0x |
|
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€189
|
$14.0B |
N/A |
N/A |
|
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 160
|
$13.8B |
9.7x |
30.5x |
|
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€98
|
$13.8B |
2.8x |
11.4x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€46
|
$13.6B |
4.4x |
11.7x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$44
|
$13.4B |
7.0x |
-4.2x |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$164
|
$13.4B |
3.2x |
14.2x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$136
|
$12.9B |
4.5x |
19.5x |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 25
|
$12.9B |
2.2x |
13.5x |
|
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$210
|
$12.8B |
3.2x |
13.5x |
|
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 10
|
$12.7B |
3.2x |
12.8x |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€138
|
$12.7B |
2.9x |
7.5x |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 110
|
$12.7B |
26.8x |
-1262.1x |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$83
|
$12.6B |
14.1x |
-34.2x |
|
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$12.4B |
2.1x |
14.0x |
|
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$25
|
$12.4B |
N/A |
N/A |
|
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 28
|
$12.1B |
3.6x |
8.5x |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 415
|
$11.8B |
42.1x |
-255.2x |
|
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.7B |
0.3x |
5.0x |
|
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€70
|
$11.7B |
5.2x |
14.1x |
|
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$54
|
$11.5B |
5.5x |
15.1x |